AMRX
Price
$8.42
Change
+$0.05 (+0.60%)
Updated
Jul 3 closing price
Capitalization
1.87B
33 days until earnings call
PRGO
Price
$27.20
Change
-$0.06 (-0.22%)
Updated
Jul 3 closing price
Capitalization
4.35B
32 days until earnings call
Interact to see
Advertisement

AMRX vs PRGO

Header iconAMRX vs PRGO Comparison
Open Charts AMRX vs PRGOBanner chart's image
Amneal Pharmaceuticals
Price$8.42
Change+$0.05 (+0.60%)
Volume$898.79K
Capitalization1.87B
Perrigo
Price$27.20
Change-$0.06 (-0.22%)
Volume$454.25K
Capitalization4.35B
AMRX vs PRGO Comparison Chart in %
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. PRGO commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a StrongBuy and PRGO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (AMRX: $8.42 vs. PRGO: $27.20)
Brand notoriety: AMRX and PRGO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 47% vs. PRGO: 36%
Market capitalization -- AMRX: $1.87B vs. PRGO: $4.35B
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. PRGO’s [@Pharmaceuticals: Other] market capitalization is $4.35B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whilePRGO’s FA Score has 1 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • PRGO’s FA Score: 1 green, 4 red.
According to our system of comparison, AMRX is a better buy in the long-term than PRGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 6 TA indicator(s) are bullish while PRGO’s TA Score has 5 bullish TA indicator(s).

  • AMRX’s TA Score: 6 bullish, 4 bearish.
  • PRGO’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, PRGO is a better buy in the short-term than AMRX.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а +3.57% price change this week, while PRGO (@Pharmaceuticals: Other) price change was +2.37% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 07, 2025.

PRGO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRGO($4.35B) has a higher market cap than AMRX($1.87B). PRGO has higher P/E ratio than AMRX: PRGO (341.25) vs AMRX (90.00). PRGO YTD gains are higher at: 8.031 vs. AMRX (6.313). PRGO has higher annual earnings (EBITDA): 525M vs. AMRX (400M). PRGO has more cash in the bank: 751M vs. AMRX (91.5M). AMRX has less debt than PRGO: AMRX (2.75B) vs PRGO (4.07B). PRGO has higher revenues than AMRX: PRGO (4.66B) vs AMRX (2.39B).
AMRXPRGOAMRX / PRGO
Capitalization1.87B4.35B43%
EBITDA400M525M76%
Gain YTD6.3138.03179%
P/E Ratio90.00341.2526%
Revenue2.39B4.66B51%
Total Cash91.5M751M12%
Total Debt2.75B4.07B68%
FUNDAMENTALS RATINGS
AMRX vs PRGO: Fundamental Ratings
AMRX
PRGO
OUTLOOK RATING
1..100
2459
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
60100
SMR RATING
1..100
9991
PRICE GROWTH RATING
1..100
4654
P/E GROWTH RATING
1..100
282
SEASONALITY SCORE
1..100
n/a40

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (71) in the Pharmaceuticals Other industry is in the same range as AMRX (90) in the Pharmaceuticals Major industry. This means that PRGO’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (60) in the Pharmaceuticals Major industry is somewhat better than the same rating for PRGO (100) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew somewhat faster than PRGO’s over the last 12 months.

PRGO's SMR Rating (91) in the Pharmaceuticals Other industry is in the same range as AMRX (99) in the Pharmaceuticals Major industry. This means that PRGO’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Price Growth Rating (46) in the Pharmaceuticals Major industry is in the same range as PRGO (54) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to PRGO’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is in the same range as AMRX (28) in the Pharmaceuticals Major industry. This means that PRGO’s stock grew similarly to AMRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXPRGO
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
60%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
65%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
58%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 5 days ago
60%
Declines
ODDS (%)
Bearish Trend about 1 month ago
78%
Bearish Trend 3 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
75%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTHNX46.010.37
+0.81%
FullerThaler Behavioral Sm-Cp Eq Inv
QUERX21.630.16
+0.75%
AQR Large Cap Defensive Style R6
FCGIX20.640.12
+0.58%
NYLI PineStone Global Equity Class I
BRIFX16.460.07
+0.43%
Baron Real Estate Income Retail
TINFX26.110.01
+0.04%
Thornburg International Growth R5